Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...
Acadia Pharmaceuticals (ACAD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
Acadia Pharmaceuticals Inc. ACAD is a biopharmaceutical company focused on developing innovative medicines to address unmet medical needs in central nervous system (CNS) disorders. The company’s lead ...
Zacks.com on MSN
FTRE vs. ACAD: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Fortrea Holdings Inc. (FTRE) or Acadia Pharmaceuticals (ACAD). But which of these two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results